JOHN JOHNSON
CIK 1410781 · Executive Chairman · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.85M
Companies
13
Total Filings
96
Lifetime Open-Market Net
-$3.23M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XERS | Director | 683,083 | $6.79 | $4.64M | -$1.85M | 10 | 2026-06-05 |
| VSTM | Director | 52,666 | $4.10 | $215.9K | $0 | 10 | 2026-05-26 |
| AXGN | Director | 0 | $43.00 | $0 | -$1.91M | 10 | 2026-05-08 |
| Applied Therapeutics, Inc. (APLT) Delisted | Executive Chairman | 500,000 | $0.10 | $51.5K | $0 | 1 | 2024-12-20 |
| Strongbridge Biopharma plc (SBBP) Delisted | Chief Executive Officer | 0 | $2.00 | $0 | $0 | 11 | 2021-10-06 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Director | 0 | — | — | $0 | 8 | 2020-07-02 |
| MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) Delisted | Chief Executive Officer | 37,400 | — | — | -$72.4K | 5 | 2019-07-02 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Director | 0 | — | — | $0 | 5 | 2018-02-13 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Director | — | $15.00 | — | $0 | 1 | 2018-02-05 |
| MELINTA THERAPEUTICS, INC. /NEW/ (CEMP) Delisted | Director | 10,000 | — | — | $0 | 6 | 2017-01-05 |
| Ocera Therapeutics, Inc. (TZYM) Delisted | Director | — | — | — | $0 | 2 | 2012-08-09 |
| SAVIENT PHARMACEUTICALS INC (SVNT) Delisted | Chief Executive Officer | 256,350 | — | — | $110.5K | 6 | 2012-01-04 |
| IMCLONE SYSTEMS INC (IMCL) Delisted | CEO | 0 | — | — | $500.0K | 4 | 2008-11-24 |
Recent Filings · Page 9 of 10
96 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-02-02 | — | Grant (A) | +349,780 | $0 | |
| 2012-01-05 | — | Grant (A) | +25,000 | $0 | |
| 2012-01-04 | SAVIENT PHARMACEUTICALS INC (SVNT) Delisted | Sell (S) | −17,650 | -$40.6K | EDGAR |
| 2011-11-22 | SAVIENT PHARMACEUTICALS INC (SVNT) Delisted | Buy (P) | +5,000 | $11.5K | EDGAR |
| 2011-11-21 | SAVIENT PHARMACEUTICALS INC (SVNT) Delisted | Buy (P) | +11,000 | $25.2K | EDGAR |
| 2011-11-07 | — | Buy (P) | +2,500 | $16.7K | |
| 2011-09-16 | SAVIENT PHARMACEUTICALS INC (SVNT) Delisted | Buy (P) | +28,000 | $114.5K | EDGAR |
| 2011-08-30 | — | Grant (A) | +10,443 | $0 | |
| 2011-04-21 | Ocera Therapeutics, Inc. (TZYM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-02-02 | SAVIENT PHARMACEUTICALS INC (SVNT) Delisted | Grant (A) | +230,000 | $2.12M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.